A Biomarker Panel for Risk Stratification of Ovarian Tumors
A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report
A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism
A Review of Type 2 Diabetes Drug Classes
A Selection of Significant Papers from the Past Year as Recommended by the European Endocrine Disease 2006 Advisory Panel
A Selection of Significant Papers from the Past Year as Recommended by the US Endocrine Disease 2006 Advisory Panel
A United Nations Resolution on Diabetes The Result of a Joint Effort
A United Nations Resolution on Diabetes The Result of a Joint Effort
Abdominal Obesity and Type 2 Diabetes
Abnormal Uterine Bleeding During the Reproductive Years — Terminology and Treatment
Accumulating Evidence for Improved Outcomes Using hMG versus rFSH Preparations in Assisted Reproduction Technology Cycles
Acromegaly in Pregnancy—An Overview of the Key Issues
Acromegaly—An Update on Clinical Approach and Management
Acromegaly—An Update on Clinical Approach and Management
Acromegaly—An Update on Clinical Approach and Management
Acromegaly—An Update on Clinical Approach and Management
Adding to the Armamentarium for the Treatment of Diabetes Mellitus
Addison's disease presenting with idiopathic intracranial hypertension in a 24-year-old woman: a case report
Adrenocortical oncocytic neoplasm presenting with Cushing's syndrome: a case report
Advances in Diabetes Diagnostics
Advances in Diabetic Retinopathy
Advances in Fertility Preservation in Young Female Cancer Patients
Advances in Insulin Therapy Physiological Replacement with Insulin Analogs
Advances in Our Understanding of Acromegaly – Is There an Optimal Management Regimen?
Advances in Our Understanding of Acromegaly – Is There an Optimal Management Regimen?
Advances in Our Understanding of Hyperthyroidism-associated Bone Loss
Advances in Our Understanding of Hyperthyroidism-associated Bone Loss
Advances in Our Understanding of Pituitary Adenoma
Advances in Our Understanding of Pituitary Adenoma
Advances in Surgery for Pituitary Tumors
Advances in Surgery for Pituitary Tumors
Advances in the Combined Management of Hyperglycemia and Dyslipidemia in Type 2 Diabetes
Advances in the Diagnosis and Management of Differentiated Thyroid Cancer
Advances in the Diagnosis and Management of Differentiated Thyroid Cancer
Advances in the Diagnosis and Treatment of Painful Diabetic Neuropathy
Advances in the Diagnosis, Treatment and Molecular Genetics of Pituitary Adenomas in Childhood
Advances in the Diagnosis, Treatment and Molecular Genetics of Pituitary Adenomas in Childhood
Advances in the Evaluation and Treatment of Osteoporosis— Is There an Optimal Regimen?
Advances in the Evaluation and Treatment of Osteoporosis—Is There an Optimal Regimen?
Advances in the Genetics of Type 2 Diabetes Mellitus in the Light of Personalized Healthcare
Advances in the Genetics of Type 2 Diabetes Mellitus in the Light of Personalized Healthcare
Advances in the Management of Differentiated Thyroid Cancer—Is There an Optimal Regimen?
Advances in the Prognosis and Treatment of Medullary or Anaplastic Thyroid Cancer
Advances in the Treatment of Differentiated Thyroid Cancer
Advances in the Treatment of Erectile Dysfunction
Advances in the Treatment of Graves’ Disease – A Focus on Rituximab
Advances in the Understanding of Adult Growth Hormone Deficiency Syndrome – Diagnosis, Epidemiology and Management
Advances in Treatment Options for Polycystic Ovary Syndrome
Advances in Understanding Glucose Variability and the Role of Continuous Glucose Monitoring
Advancing Beyond Basal Insulin Therapy in Patients with Type 2 Diabetes
Advancing Insulin Therapy—An Insulin Pump or a Basal–Prandial Insulin Regimen?
Advantages and Disadvantages of Realtime Continuous Glucose Monitoring in People with Type 2 Diabetes
AGE, RAGE and Diabetic Nephropathy
AGE, RAGE, and Diabetic Nephropathy
Aggressive Management of Blood Glucose
Alpha-cell Function in Type 2 Diabetes
Alpha-cell Function in Type 2 Diabetes
An Evidence-based Approach to the Clinical Use of Dietary Supplements and Nutraceuticals
An Update on Female Puberty
An Update on Pharmacological Treatment of Erectile Dysfunction
An Update on Pharmacological Treatment of Erectile Dysfunction
An Update on Pharmacological Treatment of Erectile Dysfunction
An Update on Pharmacological Treatment of Erectile Dysfunction
An Update on Polycystic Ovary Syndrome
An Update on Polycystic Ovary Syndrome
Androgen Deprivation Therapy and Neuroendocrine Differentiation in Prostate Carcinoma A Possible Inductive Role
Androgen Deprivation Therapy and Neuroendocrine Differentiation in Prostate Carcinoma – A Possible Inductive Role
Androgen Replacement in Women
Angiotensin Receptor Blockers and Type 2 Diabetic Nephropathy
Angiotensin Receptor Blockers and Type 2 Diabetic Nephropathy
Anti-diabetic Treatment in Obese Patients with Type 2 Diabetes Effects of Medication on Body Weight
Anti-diabetic Treatment in Obese Patients with Type 2 Diabetes Effects of Medication on Body Weight
Antioxidants, Diabetes, and Endothelial Dysfunction
Antitumour Effects of Somatostatin Analogues in the Treatment of Neuroendocrine Tumours
Are We Achieving Pharmacological Disease Control in Acromegaly?
As Use of Herbal Remedies Soars, Patients Taking These and Cardiovascular Medications May be at Heightened Risk of Dangerous, Potentially Life-Threatening Interactions
ASU and Mayo Clinic Partner to Combat Metabolic Syndrome
Attaining Treatment Goals as a Measure of Therapy Benefits in Type 2 Diabetes
Autonomic Neuropathy Is Treatable
Balancing Efficacy and Tolerability Issues with Statin Therapy— Considerations for the Use of Pitavastatin in Special Patient Populations
Barriers and Behaviors in Blood Glucose Monitoring
Basal InslinMyths and Realities
Behavioral Factors Influencing Health Outcomes in Youth with Type 1 Diabetes
Benefits and Consequences of Testosterone Replacement Therapy: A Review
Beta-cell Defects in Type 2 Diabetes and the Possibility of Treatment Options with GLP-1-based Therapies
Beta-cell Defects in Type 2 Diabetes and the Possibility of Treatment Options with GLP-1-based Therapies
Beta-cell-based Therapies for Type 2 Diabetes
Beyond the Diabetes Control and Complications Trial—Addressing Weight Gain in Type 1 Diabetes
Bile Acid Sequestrants in Type 2 Diabetes
Biphasic Insulin Aspart 30 in Insulin Initiation
Biphasic Insulin Aspart 30 Treatment Option in Children and Adolescents
Blood Glucose and Bodyweight in Type 2 Diabetes – Are These Compatible Treatment Targets?
Blood Glucose Monitoring In Pediatric Patients— Looking Toward Better Diabetes Management and Perspectives for the Future
Blood Glucose Monitoring In Pediatric Patients— Looking Toward Better Diabetes Management and Perspectives for the Future
Bone Metabolism During Chronic Growth Hormone Deficiency Experimental and Clinical Studies
Bone Metabolism During Chronic Growth Hormone Deficiency – Experimental and Clinical Studies
Bone Metabolism During Chronic Growth Hormone Deficiency – Experimental and Clinical Studies
BRIDGES – Funding Opportunities for Translational Research in Diabetes
BRIDGES—Funding Opportunities for Translational Research in Diabetes
Cadiovascular Risk Factors in Metabolic Syndrome Impact of Insulin Resistance on Lipids, Hypertension, and the Development of Diabetes and Cardiac Events
Can Blood Glucose Monitoring be Simplified/Modified in Order to Achieve Better Diabetes Management—Perspectives for the Future
Cardiovascular Consequences of a Mutant Thyroid Hormone Receptor α1
Cardiovascular Consequences of a Mutant Thyroid Hormone Receptor α1
Cardiovascular Dysfunction in Chronic Diabetes
Cardiovascular Health in Children with Diabetes
Cardiovascular Risk in Type 2 Diabetes – Reflecting on the ADVANCE Study
Cardiovascular Risk in Type 2 Diabetes – Reflecting on the ADVANCE Study
Cell Therapy for Diabetic Retinopathy—A Work in Progress
Challenges in the Management of Type 2 Diabetes in the Elderly
Challenges in the Management of Type 2 Diabetes in the Elderly
Children and Diabetes—The Second Campaign Year, No Time to Lose
Children and Diabetes—The Second Campaign Year, No Time to Lose
Clinical Aspects of Continuous Glucose Monitoring
Clinical Experience with Biphasic Insulin Aspart 30 (NovoMix® 30)
Clinical Follow-up of Long-term Treatments for Hyperprolactinaemia in Women
Clinical Follow-up of Long-term Treatments for Hyperprolactinaemia in Women
Cobalamin deficiency resulting in a rare haematological disorder: a case report
Combination Oral Agent Therapy in the Treatment of Type 2 Diabetes
Congenital Hypothyroidism—Monitoring Thyroid Function in Infants
Congenital Hypothyroidism—Monitoring Thyroid Function in Infants
Consequences of the Use of Low Blood-spot Thyroid-stimulating Hormone Cut-offs for the Neonatal Screening of Congenital Hypothyroidism
Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in Children with Type 1 Diabetes—The Pros and Cons
Continuous Subcutaneous Insulin Infusion and Hypoglycemia
Current and Future Perspectives in Thyroid Carcinoma Treatment
Current Issues and New Developments in the Endocrine Care of Climacteric Women
Current Issues and New Developments in the Endocrine Care of Climacteric Women
Current Understanding and Treatment of Differentiated Thyroid Cancer in Children—A Review
Degludec – First of a New Generation of Insulins
Delivery by Design: Pens for Injectable Therapies
Depression, Antidepressant Medication, and the Risk of Developing Type 2 Diabetes
Detection of Ischemia in Patients with Asymptomatic Diabetes
Developments in Digestive Tract Neuroendocrine Tumors and Pheochromocytomas/Paragangliomas—A Narrative Review
Developments in Digestive Tract Neuroendocrine Tumours and Pheochromocytomas/Paragangliomas – A Narrative Review
Developments in Glycemic Control — Will New Concepts Mean Improved Management of Diabetes?
Developments in Glycemic Control — Will New Concepts Mean Improved Management of Diabetes?
Diabetes and Cardiovascular Risk
Diabetes and Dementia
Diabetes and Depression – A Burdensome Co-morbidity
Diabetes and Oral Health—Current Concepts Regarding Periodontal Disease and Dental Caries
Diabetes and Stem Cells—A 10-year Perspective
Diabetes and Stem Cells—A 10-year Perspective
Diabetes and the Alpha Cell
Diabetes and the Brain—An Overview of Existing Knowledge and Discussions and Future Implications
Diabetes and the Disadvantaged and Vulnerable
Diabetes and the Disadvantaged and Vulnerable
Diabetes and Tuberculosis – Old Associates Posing a Renewed Public Health Challenge
Diabetes and Tuberculosis – Old Associates Posing a Renewed Public Health Challenge
Diabetes as a Paracrinopathy of the Islets of Langerhans
Diabetes Educators in Primary Care—A Natural Fit
Diabetes in Sub-Saharan Africa – Overview of a Looming Health Challenge
Diabetes in Sub-Saharan Africa – Overview of a Looming Health Challenge
Diabetes Risk Scores in 2011
Diabetes Weight Management in Clinical Practice—The Why WAIT Model
Diabetes, Insulin and Pregnancy
Diabetes-associated Erectile Dysfunction
Diabetes-induced Embryopathy—Is Prevention Feasible?
Diabetes—A Pediatric Perspective
Diabetes—A Pediatric Perspective
Diabetic Cardiovascular Autonomic Nerve Dysfunction
Diabetic Cardiovascular Autonomic Neuropathy
Diabetic control and atypical antipsychotics: a case report
Diabetic fetopathy associated with bilateral adrenal hyperplasia and ambiguous genitalia: a case report
Diabetic Foot Complications
Diabetic Foot Complications
Diabetic Gluco-lipotoxic Cardiomyopathy – Amendable by Metabolic Manipulation?
Diabetic Nephropathy and Oxidative Stress
Diabetic Nephropathy and Oxidative Stress
Diagnosis and Management of Acromegaly in 2012
Diagnosis and Management of Acromegaly in 2012
Dilemmas Associated with Hormone Therapy for Post-menopausal Women
Dipeptidyl Peptidase-4 Inhibition
Dipeptidyl Peptidase-4 Inhibition in the Management of Type 2 Diabetes
Dipeptidyl Peptidase-4 Inhibition – Advances in our Understanding of Diabetes Management
Dipeptidyl Peptidase-4 Inhibition – Advances in our Understanding of Diabetes Management
Dipeptidyl Peptidase-4 Inhibitors and the Management of Hyperglycemia
Dipeptidyl Peptidase-4 Inhibitors as Add-on Therapy to Metformin
Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapy
Dispelling the Myths about Rarely Diagnosed Pituitary Disorders
Distal migration of a floating carotid thrombus in a patient using oral contraceptives: a case report
Doing More with What We Already Know—Prevention and Improved Coverage of Healthcare for Diabetes
Doing More with What We Already Know—Prevention and Improved Coverage of Healthcare for Diabetes
DPP-4 Inhibition as a Newly Emerging Therapy for Type 2 Diabetes
Drug Profile – Saxagliptin, a Novel Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes
Drug Profile—Saxagliptin, a Novel Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes
Early Glomerular Filtration Rate Loss as a Marker of Diabetic Nephropathy
Early Glomerular Filtration Rate Loss as a Marker of Diabetic Nephropathy
Effectively Managing Type 1 Diabetes in Children – Education and Optimising New Technology
Effects of Δ-5 and Δ-4 Androgens on the Brain
Effects of Δ-5 and Δ-4 Androgens on the Brain
Electro-stimulation Parameter for Neuropathy
Electro-stimulation Parameter for Neuropathy
Emerging Aspects of Turner Syndrome
Encouraging Effective Self-management in Diabetes
Endothelin Receptor Antagonists in Diabetic Nephropathy
Epidemiology and Classification of Chronic Kidney Disease and Management of Diabetic Nephropathy
Epidemiology and Classification of Chronic Kidney Disease and Management of Diabetic Nephropathy
Erectile Dysfunction
Erectile Dysfunction
Erectile Performance - A Barometer of a Man's Health
Erectile Performance—A Barometer of a Man’s Health
Erythropoiesis-stimulating Agents Present and Future
Erythropoiesis-stimulating Agents – Present and Future
Erythropoiesis-stimulating Agents – Present and Future
Evidence for Anti-vascular Endothelial Growth Factor Treatment of Diabetic Macular Oedema
Exenatide A Novel Treatment to Manage Type 2 Diabetes Mellitus
Exenatide A Novel Treatment to Manage Type 2 Diabetes Mellitus
Exercise and Insulin Sensitivity—Where Do We Stand? You’d Better Run!
Exercise and Insulin Sensitivity—Where Do We Stand? You’d Better Run!
Extra-hepatic Acromegaly
Ezetimibe in the Treatment of Patients with Metabolic Diseases
Familial Isolated Pituitary Adenomas
Familial Isolated Pituitary Adenomas
Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report
Fatigue in Adults with Type 2 Diabetes – An Overview of Current Understanding and Management Approaches
Fatigue in Adults with Type 2 Diabetes— An Overview of Current Understanding and Management Approaches
Fenofibrates and the Prevention of Cardiovascular Risk
Fibrates - The Other Life-saving Lipid Drugs
Fibrates – The Other Life-saving Lipid Drugs
Focus on Primary Hyperparathyroidism – Diagnosis, Management and the Role of Calcimimetics
Foreward
Fractionated Stereotactic Radiotherapy as an Adjuvant Therapy for Pituitary Adenomas
Fracture Risk Following Bariatric Surgery
Future Perspectives in Glucose Monitoring Sensors
Gamma Knife Radiosurgery in Pituitary Adenomas
Gastric Contractility Modulation in the Management of Type 2 Diabetes
Gene Variants for Obesity and Type 2 Diabetes – A Shared Aetiology?
Generalised Glucocorticoid Resistance
Generalised Glucocorticoid Resistance
Genetics or Lifestyle – How Do We Prevent Diabetes?
Ghrelin and Cardiovasculature
Gliptin Therapies for Inhibiting Dipeptidyl Peptidase-4 in Type 2 Diabetes
Glucagon Testing in Adult Growth Hormone Deficiency – Current Status and Future Perspectives
Glucagon Testing in Adult Growth Hormone Deficiency— Current Status and Future Perspectives
Glucose and Glycated Haemoglobin Point-of-care Testing and Early Diagnosis of Diabetes and Pre-diabetes
Glucose Control in the Critically Ill Patient Utilizing Computerized Intravenous Insulin Dosing
Glycemic Variability and the Role It Should Play in Diabetes Management and Blood Glucose Monitoring
Gonadotrophic Hormones – An Overview of their Involvement in Gonadal and Extragonadal Tumours
Growth Hormone Deficiency During the Transition Phase
Growth Hormone Deficiency During the Transition Phase
Growth Hormone Deficiency in Autoimmune Pituitar y Disorders
Growth Hormone Deficiency in Autoimmune Pituitary Disorders
Growth Hormone Deficiency In Autoimmune Pituitary Disorders
Growth Hormone Deficiency – Difficulties in Diagnosis and Management
Growth Hormone Treatment in Children Born Small for Gestational Age— Adult Height and Metabolic Consequences
Guideline-orientated Diagnosis of Thyroid Nodules
Guideline-orientated Diagnosis of Thyroid Nodules
Guidelines for the practice of diabetes education
Halting the Progression of Diabetic Nephropathy
Hashitoxicosis – Three Cases and a Review of the Literature
HbA1c Reduction with Basal Insulin in Type 2 Diabetes Mellitus
Hormone Therapy plus mTOR Inhibitors in the Treatment of Endometrial Carcinoma
How Iodide Reaches its Site of Utilisation in the Thyroid Gland Involvement of Solute Carrier 26A4 (Pendrin) and Solute Carrier 5A8 (Apical Iodide Transporter)
How Should Diabetes Be Treated to Minimize the Risk of Cardiovascular Complications?
How to Manage Treatment of Hypothyroidism in Patients with Cardiac Disease
Hyperprolactinaemia The Essentials
Hyperprolactinaemia - Differential Diagnosis, Investigation and Management
Hyperprolactinaemia in Children A Common Diagnostic Dilemma
Hyperprolactinaemia in Children – A Common Diagnostic Dilemma
Hyperprolactinaemia in Children – A Common Diagnostic Dilemma
Hyperprolactinaemia – Differential Diagnosis, Investigation and Management
Hyperprolactinaemia – Differential Diagnosis, Investigation and Management
Hyperprolactinaemia – The Essentials
Hyperprolactinemia and the Dopamine Receptor
Hyperprolactinemia and the Dopamine Receptor
Hypertension in Postmenopausal Women
Hypertension in Postmenopausal Women
Hypertension in Postmenopausal Women
Hypertension in Pregnancy and Future Cardiovascular Disease
Hypertension Nephropathy Complex
Hyperthyroidism Due to Graves’ Disease – Is There an Optimal Pharmacological Treatment Regimen?
Hypoglycaemia in Type 2 Diabetes – Clinical Consequences and Impact on Treatment
Hypoglycemia - The Major Barrier to Good Glycemic Control
Hypoglycemia and the Central Nervous System
Hypoglycemia in Type 2 Diabetes—Consequences and Risk Assessment
Hypoglycemia The Major Barrier to Good Glycemic Control
Hypoglycemia—The Major Barrier to Good Glycemic Control
Hypogonadism and Testosterone Replacement Therapy
Hyponatraemia – Current Treatment Strategies and Perspectives for the Future
Hyponatraemia – Current Treatment Strategies and Perspectives for the Future
Hypothyroidism Talking Points 2006
Hypothyroidism—Talking Points 2006
Importance of Self-care Behaviors in Diabetes Management
Improving Diabetes Management and Care—Is it All About the Advancement of Pharmacotherapy?
Improving Glycaemic Control - A Mandatory Action Calling for Effective Therapeutic Management
Improving Glycaemic Control – A Mandatory Action Calling for Effective Therapeutic Management
Improving Glycaemic Control – A Mandatory Action Calling for Effective Therapeutic Management
Improving Glycaemic Control – A Mandatory Action Calling for Effective Therapeutic Management
Improving Glycaemic Control – A Mandatory Action Calling for Effective Therapeutic Management
Improving Point-of-care Testing with Automated Identification Technologies
Improving Point-of-care Testing with Automated Identification Technologies
Improving Point-of-care Testing with Automated Identification Technologies
Improving Quality of Life in Patients with Pituitary Tumours
In Pursuit of an Ideal – A Perspective on Non-Invasive Continuous Glucose Monitoring
In Pursuit of an Ideal – A Perspective on Non-Invasive Continuous Glucose Monitoring
In Search of Biomarkers—Opportunities in Primary Ovarian Insufficiency
In Search of Biomarkers—Opportunities in Primary Ovarian Insufficiency
Incidence of Hypoglycaemia in Patients with Type 2 Diabetes – A Subgroup Analysis from the GINGER study
Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes
Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes
Incretin Mimetics in the Treatment of Type 2 Diabetes Mellitus
Incretin Mimetics in the Treatment of Type 2 Diabetes Mellitus
Incretin Mimetics in the Treatment of Type 2 Diabetes Mellitus
Incretin-based Therapies for Type 2 Diabetes—Comparisons Between Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
Incretin-based Therapy and the Prevention of Hypoglycaemia
Inflammation in Pediatric Patients with Type 1 Diabetes—An Early Predictor of Complications?
Inflammation, Oxidative Stress, and the Metabolic Syndrome
Inhaled Human Insulin (EXUBERA®)
Inhaled Human Insulin (Exubera®): An Opportunity for Improving Long-Term Glycaemic Control in Patients with Diabetes?
Inhaled Insulin in Clinical Practice A Focus on Pulmonary Safety
Inhaled Insulin Its Incorporation into the Diabetes Treatment Regimen
Inhaled InsulinA New Development in Glycemic Control for Patients with Diabete
Inhaled InsulinA New Insulin Delivery System
Initiation and Adjustment of Therapy in Type 2 Diabetes
Initiation of Biphasic Insulin Aspart in a Patient Failing Basal Insulin Treatment
Initiation of Insulin Treatment in Type 2 Diabetes Mellitus
Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II
Insulin Initiation in Patients not Adequately Controlled on Oral Agents
Insulin Resistance, the Metabolic Syndrome and Renal Failure Is There a Special Problem for Patients Treated with Peritoneal Dialysis?
Insulin Resistance, the Metabolic Syndrome and Renal Failure – Is There a Special Problem for Patients Treated with Peritoneal Dialysis?
Insulin Resistance, the Metabolic Syndrome and Renal Failure – Is There a Special Problem for Patients Treated with Peritoneal Dialysis?
Intensive Treatment of Type-1 Diabetes The Balance of Benefits and Risks in the DCCT/EDIC Study
International Diabetes Federation - The Global Voice for Diabetes
International Diabetes Federation – The Global Voice for Diabetes
International Diabetes Federation –Putting Women and Diabetes on the Global Agenda
International Diabetes Federation— Putting Women and Diabetes on the Global Agenda
International Menopause Society — Updated Recommendations on Post-menopausal Hormone Therapy
International Menopause Society — Updated Recommendations on Post-menopausal Hormone Therapy
Introduction of New Recombinant Insulin-like Growth Factor - Current and Future Perspectives
Investigating Inhaled Insulin
Investigation, Treatment and Monitoring of Late-onset Hypogonadism
Investigation, Treatment and Monitoring of Late-onset Hypogonadism
Investigation, Treatment and Monitoring of Late-onset Hypogonadism
Iodine-131 Metaiodobenzylguanidine for the Treatment of Neuroendocrine Tumors
Is A1C the Best Measure of Glycemic Control?
Is A1C the Best Measure of Glycemic Control?
Is Prevention the Solution to the Worldwide Epidemic Explosion of Type 2 Diabetes Mellitus?
Is Prevention the Solution to the Worldwide Epidemic Explosion of Type 2 Diabetes Mellitus?
Islet Cell Function Its Role in the Onset and Progression of Type 2 Diabetes
Islet Cell Function – Its Role in the Onset and Progression of Type 2 Diabetes
La Glucemia y el Peso Corporal en la Diabetes Tipo 2: ¿Son éstos Objetivos de Tratamiento Compatibles?
Lanreotide Autogel Therapy in Patients with Acromegaly –Current Role and Perspectives for the Future
Lanreotide Depot in the Management of Acromegalic Patients
Laparoscopic Radical Hysterectomy for Early-stage Cervical Cancer
Laparoscopic resection of a primary hydatid cyst of the adrenal
Late-onset Hypogonadism and Associated Morbidities in Ageing Men
Liraglutide – A Once-daily Human Glucagon-like Peptide-1 Analogue Treatment for Type 2 Diabetes
Lixisenatide—Once-daily Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes
Lixisenatide—Once-daily Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes
Localized amyloidosis presenting with a penile mass: a case report
Long-term Glycemic Control in Patients with Diabetes?
Lowering Risks Associated with Obstetrics/Gynecology Laparoscopic Procedures by Providing Simulation Training
Management of Cardiovascular Risk Factors in Racial and Ethnic Minorities with Type-2 Diabetes
Management of Diabetic Peripheral Neuropathic Pain
Management of Diabetic Peripheral Neuropathic Pain
Management of Dyslipidemia in Patients with Diabetes
Management of Fetal Growth Restriction
Management of genital Chlamydia trachomatis infection. A national clinical guideline
Management of Patients with Differentiated Thyroid Cancer
Management of Type 2 Diabetes - The Role of Basal Insulin
Management of Type 2 Diabetes—Reflecting on the PREDICTIVE Study Results
Managing Diabetes in Children and Adolescents—Is There an Optimal Regimen?
Managing Discordant Thyroid Function Tests
Managing Erectile Dysfunction from the Point of View of the Couple
Managing Erectile Dysfunction from the Point of View of the Couple
Managing Erectile Dysfunction from the Point of View of the Couple
Managing Type 2 Diabetes in Patients Not Controlled on Metformin
Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients
Mayo Clinic Researchers Find Dementia in Diabetics Differs from Dementia in Nondiabetics
Mayo Clinic Tests Non-Incision, Endoscopic Ulcer Repair
Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process
Mayo Researchers Find Obesity Key
Mayo-led Research Team Develop Agents That Keep Insulin Working Longer
Mechanisms for B-Cell Formation in Response to Insulin Resistance
Mechanisms for B-Cell Formation in Response to Insulin Resistance
Medical Consequences of Long-term Treatment of Acromegaly
Medical Management of Acromegaly
Medical Management of Acromegaly
Medical Management of Acromegaly
Medical Management of Hyperthyroidism
Medical Management of Hyperthyroidism
Medical Nutrition Therapy and the Prevention of Diabetes
Medical Nutrition Therapy and the Prevention of Diabetes
Medical Nutrition Therapy—The Relationship of Dietary Fat and Carbohydrate Metabolism in Patients with Type 2 Diabetes
Medical Nutrition Therapy—The Relationship of Dietary Fat and Carbohydrate Metabolism in Patients with Type 2 Diabetes
Medical Therapy for Cushing’s Disease – Past and Future Modes of Treatment
Medical Therapy for Cushing’s Disease – Past and Future Modes of Treatment
Medical Treatment of Cushing’s Disease with Pasireotide
Metabolic Control in Children with Type 1 Diabetes
Minimizing Cardiovascular Complications by Early Diagnosis of Diabetes
Mitochondria, Fatty Acids and Type 2 Diabetes Mellitus What is the Connection?
Mitochondrial Dysfunction in Obesity and Diabetes
Mitochondrial Dysfunction in Type 2 Diabetes – An Update
Mitochondrial Dysfunction in Type 2 Diabetes—An Update
Moving Beyond the Color of Skin—Providing Culturally Appropriate Diabetes Care and Education
Multinodular Goiter—Diagnostic and Treatment Considerations
Multiple Endocrine Neoplasia, Type 2
Myths, Realities and Practicalities in the Initiation and Intensification of Insulin Therapy in Type 2 Diabetes
New Approach to Declining Androgens and Sexual Apathy in Ageing Women
New Approach to Declining Androgens and Sexual Apathy in Ageing Women
New Approach to Declining Androgens and Sexual Apathy in Ageing Women
New Approach to Declining Androgens and Sexual Apathy in Aging Women
New Approach to Declining Androgens and Sexual Apathy in Aging Women
New Drugs or Established Regimens for the Management of Type 2 Diabetes – Are the Choices and Decisions Facing Consultants and Their Patients Straightforward?
No More Heart Disease— Addressing Major Modifiable Risk Factors in Type 2 Diabetes
Non-alcoholic Fatty Liver Disease and Type 2 Diabetes
Non-alcoholic Fatty Liver Disease in Children
Non-alcoholic Steatohepatitis—An Endocrine Disorder
Noonan Syndrome—Clinical Perspectives and Growth Issues
Noonan Syndrome—Historical Awareness and Genetic Issues
Northern Ireland – Regional Electronic Patient Record for Diabetes
Novel Inflammatory Cardiovascular Biomarkers – Clinical Implications
Novel Insights into the Management of Growth Hormone Deficiency
Novel Insights into the Management of Growth Hormone Deficiency
Novel Insights into the Management of Growth Hormone Deficiency
Novel Insights into the Management of Growth Hormone Deficiency
Novel Insights into the Management of Growth Hormone Deficiency
Optimal Therapy of Growth Hormone Deficiency in the Child and Adolescent
Optimal Therapy of Growth Hormone Deficiency in the Child and Adolescent
Oracle involvement in a case of AA amyloidosis: a case report
Osteoporosis in Men
Ovarian Tissue Transplantation for Fertility Preservation
Overcoming Barriers to Better Heath Outcomes in Patients with Diabetes – Improving and Balancing Patient Education and Pharmacotherapy Initiation
Overcoming Barriers to Better Heath Outcomes in Patients with Diabetes – Improving and Balancing Patient Education and Pharmacotherapy Initiation
Overcoming Psychological Barriers to Insulin Use
Overt Diabetic Nephropathy and Mineralocorticoid Receptor Antagonism
Overt Diabetic Nephropathy and Mineralocorticoid Receptor Antagonism
Oxidative Stress, Diabetes, and Its Complications
Pathophysiological Aspects of Human Obesity – What We Know in 2010
Patient Education and Breast Cancer
Patient Education in the Management of Diabetes
Patient Education in the Management of Diabetes
Patients with Diabetes Especially Should Beat the Heat
Periodontitis in Patients with Diabetes— A Complication that Impacts on Metabolic Control
Pharmacologic Treatment of Diabetic Nephropathy
Pharmacologic Treatment of Diabetic Nephropathy
Pharmacological Treatment of Painful Diabetic Neuropathy
Pioglitazone in Combination with Insulin – An Overview of Results from PROactive
Pioglitazone in Combination with Insulin—An Overview of Results from PROactive
Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case report
Positioning Glucagon-like-peptide-1-based Treatments within an Optimal Management Regimen for Type 2 Diabetes
Possible Impacts of New Accuracy Standards of Self-Monitoring of Blood Glucose
Post-menopausal Hormone Therapy Improving the Risk Benefit Ratio with Ultra-low Doses of Estrogen
Postprandial Hyperglycaemia and Cardiovascular Complications of Diabetes
Postprandial Hyperglycaemia and Cardiovascular Complications of Diabetes
Potential Advantages of a Basal–Bolus Regimen Using Insulin Glulisine as Prandial Insulin
Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism
Potential Therapeutic Role of Androgens in Cognitive Loss Associated with Hypogonadism
Precocious Puberty
Predicting and Preventing Cardiovascular Risk in Patients with Diabetes
Predicting and Preventing Cardiovascular Risk in Patients with Diabetes
Prelox® for Improvement of Erectile Quality
Premature Menopause and Sexual Outcomes
Prescribing Habits to Reduce the High Rate of Unintended Pregnancy
Prevention of Cardiovascular Risk in Diabetic Patients – An Update
Prevention of Pre-term Birth—A Challenge Not Yet Met
Prevention through Awareness - Raising Global Awareness of Diabetes and Its Complications
Prevention through Awareness – Raising Global Awareness of Diabetes and Its Complications
Progress with Closed-loop Systems in Type 1 Diabetes
Progress with Closed-loop Systems in Type 1 Diabetes
Progression from Basal to Pre-mixed or Rapid-acting Insulin—Options for Intensification and the Use of Pumps
Progression of Treatment Strategies in Type 2 Diabetes
Prolactin in Autoimmune Diseases
Prolactinoma presenting as chronic anaemia with osteoporosis: a case report
Prophylaxis against infective endocarditis. Antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures.
Public Health Practice and Diabetes—What More Can Be Done to Halt the Epidemic?
Realtime Continuous Glucose Monitoring in Children and Adolescents— An Overview of the Current Technology and its Impact on Patient Outcomes
Recent Management Controversies in Osteoporosis
Recent Management Controversies in Osteoporosis
Resistance to Thyroid Hormone and Cardiovascular Risk
Resistance to Thyroid Hormone and Cardiovascular Risk
Riedel’s thyroiditis masquerading as anaplastic thyroid carcinoma: a case report
Risk Factors in the Progression of Chronic Kidney Disease
Risk Factors in the Progression of Chronic Kidney Disease
Risk Factors in the Progression of Chronic Kidney Disease
Rituximab for the Treatment of Graves’ Orbitopathy
Rituximab for the Treatment of Graves’ Orbitopathy
Robert Costello—The Prophet of Pituitary Adenomas
Robert Costello—The Prophet of Pituitary Adenomas
Safety and Security of Menopausal Therapies
Safety and Security of Menopausal Therapies
Salmon Calcitonin and the Treatment of Acute Osteoporosis
Salmon Calcitonin in the Treatment of Osteoporosis
Screening for Type 2 Diabetes – The ADDITION Netherlands Study
Secondary Hyperparathyroidism in the Diabetic Patient with Chronic Kidney Disease
Secondary Hyperparathyroidism in the Diabetic Patient with Chronic Kidney Disease
Self Blood Glucose Measuring in the Non-insulin-requiring Diabetic Patient — To Test or Not to Test
Self Blood Glucose Monitoring in Type 2 Diabetes
Self-Monitoring of Blood Glucose in Children and Adolescents with Diabetes— Barriers, Behaviors, and the Search for Solutions
Sexual Medicine - 2005 Update on Key Treatment Issues for Men with Erectile Dysfunction and their Partners
Sexual Medicine—2005 Update on Key Treatment Issues for Men with Erectile Dysfunction and their Par tners
Sexuality and Intimacy Following Cancer
Short Review on Late-onset Hypogonadism
Short-term Withdrawal of Levothyroxine, Induced Increase of Thyroid-stimulating Hormone and an Increase Ratio of Triiodothyronine to Thyroxine
Significance of Fine-needle Aspiration Biopsy in the Pre-operative Diagnostics of the Thyroid Gland
Significance of Fine-needle Aspiration Biopsy in the Pre-operative Diagnostics of the Thyroid Gland
Significance of Fine-needle Aspiration Biopsy in the Pre-operative Diagnostics of the Thyroid Gland
Sleep Apnoea, Obesity, Diabetes and the Metabolic Syndrome
Sleep Disturbances and Glucose Homeostasis
Sleeping Beauty or the Beast? – The Metabolic Syndrome from an Obstructive Sleep Apnoea Perspective
Sodium–Glucose Co-transporter 2 Inhibition – A Novel Strategy for Glucose Control in Type 2 Diabetes
Sodium–Glucose Co-transporter 2 Inhibition—A Novel Strategy for Glucose Control in Type 2 Diabetes
Specialty Drugs for the Treatment of Short Stature in Children— Pros, Cons, and Perspectives for the Future
Statin Drug Interactions in Patients with Comorbidities and on Multiple Medications
Structures of Diabetic Foot Care
Study Shows New Approach to Prevent Antibody-Mediated Damage in Kidney Transplants
Subclinical Hypothyroidism and Cardiovascular Risk – An Overview of Current Understanding
Subclinical Hypothyroidism and Cardiovascular Risk— An Overview of Current Understanding
Subclinical Hypothyroidism—The Treatment Controversy
Surgical Indications and Results for Non-functioning Pituitary Adenomas
Surgical Indications and Results for Non-functioning Pituitary Adenomas
Surgical Procedures for Pelvic Organ Prolapse
Switching to Biphasic Insulin Aspart 30 in Patients Uncontrolled on Human Premix Insulin
T in Cheek: Buccal Testosterone as a New Treatment for Androgen Deficiency in Men
T in Cheek: Buccal Testosterone as a New Treatment for Androgen Deficiency in Men
Temozolomide in the Treatment of Aggressive Pituitary Tumors— An Overview of Existing Knowledge and Future Perspectives
Temozolomide in the Treatment of Aggressive Pituitary Tumours – An Overview of Existing Knowledge and Future Perspectives
Testosterone Clinical Associations with the Metabolic Syndrome and Type 2 Diabetes Mellitus
Testosterone Replacement Therapy and Late-onset Hypogonadism
Testosterone Replacement Therapy and Late-onset Hypogonadism
Testosterone Substitution Therapy and Women’s Sexual Health
Testosterone Substitution Therapy and Women’s Sexual Health
Testosterone Therapy and Women’s Sexuality
Testosterone Therapy and Women’s Sexuality
The Accuracy and Interferences in Self-monitoring of Blood Glucose
The Amylin Analogue Pramlintide in the Treatment of Type 1 and Type 2 Diabetes
The Australian Diabetes, Obesity, and Lifestyle Study—Profiling Diabetes and Cardiovascular Disease Risk in the Nation
The Australian Diabetes, Obesity, and Lifestyle Study—Profiling Diabetes and Cardiovascular Disease Risk in the Nation
The Challenge of Lipid Management in Patients with Diabetes or Other Endocrine Disorders
The Challenge of Managing Hypertension in Patients with Diabetes or Other Endocrine Disorders
The Challenge of Managing Hypertension in Patients with Diabetes or Other Endocrine Disorders
The Clinical Application of Inhaled Insulin
The Debate Over Testosterone Replacement in Aging Men
The Debate Over Testosterone Replacement in Aging Men
The Diabesity Epidemic
The Diabetes Interactive Diary – A Useful Tool for Diabetes Management?
The Diabetic Foot—Imaging Options and Considerations
The Difficulty of Pituitary Disorders
The Effects of Incretin Mimetics on Islet Cell Function in Type 2 Diabetes
The Effects of Incretin Mimetics on Islet Cell Function in Type 2 Diabetes
The European Endocrinology Arena – In Brief An Authoritative Round-up of Trends, Statistics and Clinical Research
The Evolving Role of the Diabetes Educator—Changing Patient Behavior in Diabetes Self-management Education
The Family's Involvement in Diabetes Care and the Problem of Miscarried Helping
The Family’s Involvement in Diabetes Care and the Problem of ‘Miscarried Helping’
The Family’s Involvement in Diabetes Care and the Problem of ‘Miscarried Helping’
The Function and Role of Dipeptidyl Peptidase-4 Inhibitors in the Management of Type 2 Diabetes
The Future of Abortion in the US
The Future of C-reactive Protein in Point-of-care Testing
The Hyperglycaemic Continuum - Enough Evidence for Early Use of Glitazones?
The Hypothalamo–Pituitary–Adrenocortical Axis – An Overview of the Role of Glucocorticoids in the Pathophysiology of Endocrine Disorders and Perspectives for the Future
The Hypothalamo–Pituitary–Adrenocortical Axis—An Overview of the Role of Glucocorticoids in the Pathophysiology of Endocrine Disorders and Perspectives for the Future
The Impact of Treatment of Obstructive Sleep Apnoea Syndrome on Glycaemic Control in Patients with Diabetes Mellitus
The Importance of Good Insulin Injection Practices in Diabetes Management
The Importance of Monitoring Blood Glucose
The Importance of Reducing Hyperglycemia While Preserving Insulin Secretion—The Rationale for Sodium-coupled Glucose Co-transporter 2 Inhibition in Diabetes
The Importance of Testing for Pre-diabetes—Using the Right Tool
The Imprecise Interpretation of ‘Clinically Significant’ Pituitary Tumors
The Incretin System and Type 2 Diabetes
The Limitations of Risk-based Strategies for Vaccination of the 19–26-year-old Female Population
The management of acute parathyroid crisis secondary to parathyroid carcinoma: a case report
The Management of Post-prandial Glucose
The Management of Type 2 Diabetes in 2007 — Insights from the 67th Scientific Sessions of the American Diabetes Association
The Meaning of Cardiometabolic Risk in Hypertensive Patients
The Meaning of Cardiometabolic Risk in Hypertensive Patients
The Potential of Intranasal Insulin in the Management of Metabolic Disorders
The Potential of Intranasal Insulin in the Management of Metabolic Disorders
The Potential of Phosphorus Metabolic Magnetic Resonance Imaging and Spectroscopy for Assessing the Risk of Developing Foot Ulceration in Diabetes
The PROactive and DREAM Studies
The Problem of the Aggressive Pituitary Tumor
The Relationship Between Periodontitis and Glycaemic Control in Type 2 Diabetes
The Risks and Benefits of Hormone Replacement Therapy
The Risks and Benefits of Hormone Replacement Therapy
The Role of Advanced Glycation End-products in the Etiology of Insulin Resistance and Diabetes
The Role of Cardiac Troponins – Today and Tomorrow
The Role of Devices in Diabetes Management
The Role of Dipeptidyl Peptidase-4 Inhibitors in the Management of Type 2 Diabetes
The Role of Dipeptidyl Peptidase-4 Inhibitors in the Management of Type 2 Diabetes
The Role of Gastrointestinal Metabolic Surgery in the Management of Type 2 Diabetes
The Role of Group Care in the Management of Type 2 Diabetes
The Role of Insulin in the Regulation of PEPCK and Gluconeogenesis In Vivo
The Role of Islet Cell Transplantation in the Management of Diabetes
The Role of Islet Cell Transplantation in the Management of Diabetes
The Role of Islet-cell Function in the Onset and Progression of Type 2 Diabetes
The Role of Pen Devices in Making Mealtime Control Achievable
The Role of Recombinant Human Growth Hormone Biosimilars in the Management of Growth Disorders
The Role of Statin Therapy in Primary Hyperlipidemia and Mixed Dyslipidemia
The Role of Steroids in Endothelial Function in the Ageing Male
The Role of Steroids in Endothelial Function in the Aging Male
The Role of Total Thyroidectomy in the Initial Treatment of Well-differentiated Follicular-cell-derived Thyroid Carcinomas
The Role of Vacuum Device Therapy in the Management of Erectile Dysfunction
The Role of Visceral Adipose Tissue in the Pathogenesis of Non-alcoholic Fatty Liver Disease
The Treatment of Diabetes after an Acute Ischaemic Stroke
The Treatment of Diabetes after an Acute Ischemic Stroke
The US Endocrinology Arena—In Brief An Authoritative Round-up of Trends, Statistics and Clinical Research
The Use and Abuse of Self Monitoring of Blood Glucose
The Use and Abuse of Self Monitoring of Blood Glucose
The Use and Abuse of Self Monitoring of Blood Glucose
The Use of Sorafenib in the Thyroid Cancer
The Use of Sorafenib in Thyroid Cancer
The Weight Problem in Type 2 Diabetes and How Best to Tackle It
Therapeutic Options in Patients with Microprolactinoma
Therapeutic Options in Patients with Microprolactinoma
Therapeutic Options in Patients with Microprolactinoma
Thiazolidinediones Emerging Evidence on Bone Formation
Thiazolidinediones Emerging Evidence on Bone Formation
Thiazolidinediones in Diabetes Management—An Overview of the Controversies, Current Status, and Perspectives for the Future
Thymus Dysfunction in the Development of Type 1 Diabetes and Endocrine Autoimmune Diseases
Thyroid Cancer - Changing Patterns of Diagnosis and Treatment
Thyroid Cancer—Changing Patterns of Diagnosis and Treatment
Thyroid Disease in Pregnancy
Thyroid Nodules - Management Dilemmas and Theraputic Considerations
Thyroid Nodules—Management Dilemmas and Theraputic Considerations
Thyroid-stimulating Hormone Resistance
Too Much Sitting and Metabolic Risk—Has Modern Technology Caught Up with Us?
Too Much Sitting and Metabolic Risk—Has Modern Technology Caught Up with Us?
Toxic shock syndrome responsive to steroids
Treating the Common Dyslipidemia in Patients with Type 2 Diabetes: Insights from FIELD on the Effects of Fenofibrate on CVD Risk
Treatment and Management of Hypothyroidism
Treatment of Aggressive Pituitary Adenomas and Carcinomas—An Overview
Treatment of Erectile Dysfunction
Treatment of Erectile Dysfunction
Treatment of Erectile Dysfunction
Treatment of Male Hypogonadism
Treatment of Osteoporosis in Postmenopausal Women Who Are At Risk of Fracture
Treatment Options for Charcot Neuroarthropathy
Treatment Options for Neuropathic Pain Associated with Diabetes
Triamcinolone Acetonide for the Treatment of Diabetic Macular Oedema
Triglyceride Management in Cardiovascular Risk Reduction
Triglyceride Management in Cardiovascular Risk Reduction
Triglycerides - A Variable Cardiovascular Risk Factor
Type 1 Diabetes—Pathogenesis, Prediction, and Prevention
Type 2 Diabetes—Advancing Insulin Therapy in Patients with Prior Experience of Basal Insulin plus Oral Agents
Ultrasound of the Endocrine Neck
Ultrasound of the Endocrine Neck
Ultrastructural pathology of nephropathies with organized deposits: a case series
Understanding and Identifying Pre-diabetes – Can We Halt the Diabetes Epidemic?
Understanding and Identifying Pre-diabetes – Can We Halt the Diabetes Epidemic?
Understanding and Managing Primary Hyperparathyroidism –Anything New?
Understanding Diabetic Nephropathy – Is There a Genetic Susceptibility?
Understanding the Immunology of Type 1 Diabetes – An Overview of Current Knowledge and Perspectives for the Future
Understanding the Immunology of Type 1 Diabetes— An Overview of Current Knowledge and Perspectives for the Future
Update on In Vitro Fertilization Approaches
Update on the Use of Detemir Insulin in the Management of Type 2 Diabetes
Urachal endometrioma: a case report
Uro-genital Prolapse Surgery—An Update on Post-operative Urinary Incontinence
Use of Continuous Glucose Monitoring Can Address Patient Fears and Facilitate Improved Glycaemic Management
Use of the Harmonic Scalpel in Thyroid Surgery - Review of the Literature
Using Diabetes Therapy Management Software to Support Behavior Change—A Case-based Approach
Using Professional Continuous Glucose Monitoring to Modify Eating Behavior in Patient on ‘Heart Healthy’ Diet
V-Go™—A Novel Device for Delivering Basal–Bolus Insulin Therapy to Patients with Type 2 Diabetes Mellitus
Vildagliptin An Oral Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes
Vitamin D and Bone Health—Discussion Points Following the Recent Institute of Medicine Recommendations
Vitamin D and Bone Health—Discussion Points Following the Recent Institute of Medicine Recommendations
Vitamin D and Insulin Action and Secretion –An Overview of Current Understanding and Future Perspectives
Wellbeing and Mental Status in Adult Patients with Growth Hormone Deficiency - Effects of Growth Hormone Treatment
Wellbeing and Mental Status in Adult Patients with Growth Hormone Deficiency – Effects of Growth Hormone Treatment
Wellbeing and Mental Status in Adult Patients with Growth Hormone Deficiency – Effects of Growth Hormone Treatment
What Breathing Insulin Means for Diabetes Treatment
What is Successful Islet Transplantation in 2006?
When Will We Agree on the Origin and Meaning of ‘Wellbeing’?
When Will We Agree on the Origin and Meaning of ‘Wellbeing’?
Witnessing a New Era? – The Emerging Role of Targeted Drugs in the Medical Treatment of Advanced Medullary and Anaplastic Thyroid Cancer
Witnessing a New Era?—The Emerging Role of Targeted Drugs in the Medical Treatment of Advanced Medullary and Anaplastic Thyroid Cancer
Womens Sexual Health Update on Testosterone Therapy
Wound-healing Abnormalities in Diabetes and New Therapeutic Interventions